Literature DB >> 16420511

Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.

Ricard Solà1, Marco Antonio Alvarez, Belén Ballesté, Silvia Montoliu, Mònica Rivera, Mireia Miquel, Isabel Cirera, Rosa Maria Morillas, Susanna Coll, Ramon Planas.   

Abstract

BACKGROUND: Although chronic alcohol intake and chronic hepatitis C may progress to cirrhosis and hepatocellular carcinoma (HCC), few data are available about survival and probability of developing HCC in decompensated cirrhosis of both aetiologies.
METHODS: This study identified factors related with probability of developing HCC and survival in a cohort of 377 consecutive patients with decompensated HCV-related cirrhosis (200 cases) or alcoholic cirrhosis (177 cases) without known HCC, hospitalized for their first hepatic decompensation, as well as to evaluate differences between both aetiologies. Patients were followed for a mean period of 39 +/- 2 months.
RESULTS: During follow-up, 42 patients (11.1%) developed HCC (16.5% vs 5.1%) in groups HCV and alcohol, respectively; p = 0.0008), and 131 patients (34.7%) died (42% vs 26.6% in groups HCV and alcohol, respectively; p = 0.002). Age and HCV-cirrhosis were independently related to HCC development, while baseline age and Child-Turcotte-Pugh score were independently correlated with survival.
CONCLUSION: Survival in decompensated HCV-related or alcoholic cirrhosis is influenced by age and baseline Child-Turcotte-Pugh score, without differences in cirrhosis aetiology. The risk of developing HCC is greater in HCV-related cirrhosis than in alcoholic cirrhosis.

Entities:  

Mesh:

Year:  2006        PMID: 16420511     DOI: 10.1111/j.1478-3231.2005.01181.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

Review 1.  Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Nobuyuki Toshikuni; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors:  Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

3.  Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.

Authors:  Cristina Ripoll; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Norman Grace; Andrew Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; Robert Makuch; David Patch; Daniel S Matloff
Journal:  J Hepatol       Date:  2009-03-05       Impact factor: 25.083

4.  Propranolol use in patients with cirrhosis and refractory ascites: A nationwide study.

Authors:  Yen-Chun Chen; Yun-Da Li; Chia-Ming Lu; Wei-Chun Huang; Sung-Shuo Kao; Wen-Chi Chen
Journal:  Saudi J Gastroenterol       Date:  2022 Mar-Apr       Impact factor: 2.485

5.  Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

Authors:  Ryosuke Tateishi; Takeshi Okanoue; Naoto Fujiwara; Kiwamu Okita; Kendo Kiyosawa; Masao Omata; Hiromitsu Kumada; Norio Hayashi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2014-06-15       Impact factor: 7.527

6.  Economic burden of cirrhosis in Catalonia: a population-based analysis.

Authors:  Mireia Miquel; Montserrat Clèries; Mercedes Vergara; Emili Vela
Journal:  BMJ Open       Date:  2018-03-03       Impact factor: 2.692

7.  Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway.

Authors:  John Willy Haukeland; Milada Cvancarova Småstuen; Pia Pernille Pålsdatter; Moonisah Ismail; Zbigniew Konopski; Kristin Kaasen Jørgensen; Hans Lannerstedt; Håvard Midgard
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

8.  Mortality Risk and Decompensation in Hospitalized Patients with Non-Alcoholic Liver Cirrhosis: Implications for Disease Management.

Authors:  Ming-Shun Hsieh; Kung-Chuan Cheng; Meng-Lun Hsieh; Jen-Huai Chiang; Vivian Chia-Rong Hsieh
Journal:  Int J Environ Res Public Health       Date:  2021-01-12       Impact factor: 3.390

9.  A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland.

Authors:  S A McDonald; S J Hutchinson; S M Bird; C Robertson; P R Mills; J F Dillon; D J Goldberg
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

10.  Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.

Authors:  Astrid Marot; Jean Henrion; Jean-François Knebel; Christophe Moreno; Pierre Deltenre
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.